![]() |
|||
|
Bird flu:
How big a threat? BY GREGORY MOTT The Star, 23 Oct 2005 |
|||
|
AVIAN FLU is an imminent threat to health and well-being. For birds. In Asia and Eastern Europe. That reality is easily missed in the face of warnings from government officials and public health experts of an impending global pandemic that could take millions of lives, devastate economies and require militarily-enforced quarantines. The highly virulent strain of influenza that is devastating bird populations in Asia is arousing concern among medical experts because the disease has proven to be transmissible from infected birds to humans with lethal consequences --- 60 of the 117 confirmed cases in humans have been fatal, according the World Health Organization. But nearly every human case has resulted from direct contact with an infected bird, and at this point the virus does not transmit easily from human to human. That doesn’t mean there’s no cause for concern. Experts worry that the bird flu virus could mutate in a way that would make it more easily transmissible from person to person. The WHO notes this is more likely if a large outbreak among animals occurs during the human flu season. Efforts to contain bird flu range from monitoring bird populations to expediting research to develop a vaccine for broad use should the disease begin to spread among humans. John Treanor, a professor of medicine at the University of Rochester and lead investigator in a National Institutes of Health-sponsored trial of a prospective avian flu vaccine, addresses questions in a telephone interview.
Recent
reporting on the avian flu seems to suggest that a human
pandemic is inevitable. Is that the case?
Your work is
aimed at developing a vaccine that would protect against the
disease. How would such a vaccine be used? |
If it were to work out, it would be given prophylactically in much the same way as the regular flu shot. The specific target groups would depend in part on what was judged to be the risk at the moment. I suspect that the rollout of a vaccination campaign, were that to happen, would be phased with an initial targeting of certain groups, and then a wider use later.
Would the
high-risk groups that get the regular flu shot first also be
first in line for the avian flu vaccine?
Would there
be problems of not being able to produce enough vaccine?
Will the
regular flu shot provide any protection against avian flu?
What makes
this strain of avian flu more virulent than others? Influenza viruses change a little every year… They undergo a process called antigenic drift that does allow them to reinfect people, but those reinfections tend to be much more mild. Mild, of course, is a relative term. Flu is responsible for deaths and hospitalizations, but (its impact is) ameliorated to a certain extent by the experience --- whether by vaccination or by previous infection --- that a person has had with related flu viruses. |
When a pandemic occurs, the central thing that happens is that the virus has a completely different outer coat, and that allows very rapid spread in a population that has no underlying immunity. In 1957 we had a pandemic where a new virus, an H2 virus, showed up in a population that had previously only experienced and H1. And in 1968 we had a pandemic when a new virus, an H3, showed up in a population that had only experienced H1 and H2.
In Asia, many
deaths have occurred in young people. Is that due to a lack of
previous exposure to flu?
There’s been
a bit of discussion around the idea of having Roche
Pharmaceuticals, the maker of oseltamivir, either expand and
hasten the manufacture of that drug or allow other companies to
make it. Would that drug be effective in the face of a pandemic?
As an
antiviral, would it only be used for treatment, or could it also
be used for prevention? But let’s assume for sake of argument that we are talking about a bird flu that is susceptible to these neuraminase inhibitors; we hope and believe that they probably are. Neuraminase inhibitors are clearly very effective when given prophylactically, and I suspect that they would also be very effective in preventing bird flu if taken before exposure. The issue would be whether the supply of the drug would be sufficient to provide preventive drugs to large numbers of people who would have to take this for the entire duration of the time that they were being potentially exposed. You would end up using fewer doses of the drug if you restricted use of the drug to treatment. The issue with any antiviral is whether treatment would be as effective as prophylaxis would be. Here we just don’t know. I haven’t been encouraging people to get oseltamivir, and I don’t know any myself, but I know a lot of people who do.
Can consumers
expect to see a vaccine in the near future? |
If we started to see person-to-person transmission with a virus that was the same as that or that was antigenically similar to the virus that we used to make the vaccine, then we would be a relatively easy matter to make more, although it would take time. If the virus that emerges is antigenically different from the ones that we’ve been testing, the technology is there to make the seed virus more quickly, but then it would take the amount of time that it takes to ramp up production (of a vaccine).
Most deaths
in Asia have been in people who had direct contact with diseased
birds. Should people in the US avoid contact with birds?
And so
there’s no protective benefit to be gained here by, say,
avoiding eating chicken?
How about
being around chicken on, say, a farm or farmer’s market?
|